Zydus, Daewoong sign licensing pact to develop, market Leuprolide long-acting injectable in US
Express Pharma
DECEMBER 11, 2023
Zydus Worldwide DMCC, a wholly owned subsidiary of Zydus Lifesciences and Daewoong Pharmaceutical Co announced that they have entered into an exclusive licensing agreement to co-develop and commercialise Leuprolide Acetate for Depot Suspension (RLD: Lupron Depot, AbbVie) in six dosage strengths for the United States (US) market.
Let's personalize your content